Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Gasparri

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Pharmaceutics|April 30, 2021
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid TumorsEmily Capone, Rossano Lattanzio, Fabio Gasparri, et al.
Genetic Testing and Molecular Biomarkers|January 30, 2013
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authenticationAlessio Somaschini, Nadia Amboldi, Angelo Nuzzo, et al.
Molecular Cancer Therapeutics|September 18, 2023
Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical StudiesBarbara Valsasina, Paolo Orsini, Michele Caruso, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 19, 2015
Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkersAlberto Dal Corso, Michele Caruso, Laura Belvisi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2018
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted ConjugateAndré Raposo Moreira Dias, Arianna Pina, Amelia Dean, et al.
Plos One|October 29, 2015
A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing CompoundsMarta Durlak, Cristina Fugazza, Sudharshan Elangovan, et al.
Oncotarget|October 3, 2015
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningMaria Anania, Fabio Gasparri, Elena Cetti, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Tumor Targeting with an isoDGR-Drug ConjugateSimone Zanella, Simona Angerani, Arianna Pina, et al.
Experimental Cell Research|December 9, 2014
Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancersMichele Modugno, Patrizia Banfi, Fabio Gasparri, et al.
Molecular Cancer Therapeutics|December 15, 2017
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Barbara Salom, Liviana Cozzi, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Pharmaceutics|April 30, 2021
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid TumorsEmily Capone, Rossano Lattanzio, Fabio Gasparri, et al.
Genetic Testing and Molecular Biomarkers|January 30, 2013
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authenticationAlessio Somaschini, Nadia Amboldi, Angelo Nuzzo, et al.
Molecular Cancer Therapeutics|September 18, 2023
Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical StudiesBarbara Valsasina, Paolo Orsini, Michele Caruso, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 19, 2015
Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkersAlberto Dal Corso, Michele Caruso, Laura Belvisi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2018
Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted ConjugateAndré Raposo Moreira Dias, Arianna Pina, Amelia Dean, et al.
Plos One|October 29, 2015
A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing CompoundsMarta Durlak, Cristina Fugazza, Sudharshan Elangovan, et al.
Oncotarget|October 3, 2015
Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screeningMaria Anania, Fabio Gasparri, Elena Cetti, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2017
Tumor Targeting with an isoDGR-Drug ConjugateSimone Zanella, Simona Angerani, Arianna Pina, et al.
Experimental Cell Research|December 9, 2014
Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancersMichele Modugno, Patrizia Banfi, Fabio Gasparri, et al.
Molecular Cancer Therapeutics|December 15, 2017
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and BrachyuryPaola Magnaghi, Barbara Salom, Liviana Cozzi, et al.
Pageof 4